Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.

Aghasi M, Koohdani F, Qorbani M, Nasli-Esfahani E, Ghazi-Zahedi S, Khoshamal H, Keshavarz A, Sotoudeh G.

J Sci Food Agric. 2019 Jun;99(8):3933-3940. doi: 10.1002/jsfa.9617. Epub 2019 Mar 18.

PMID:
30701554
2.

Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.

Adib M, Peytam F, Shourgeshty R, Mohammadi-Khanaposhtani M, Jahani M, Imanparast S, Faramarzi MA, Larijani B, Moghadamnia AA, Esfahani EN, Bandarian F, Mahdavi M.

Bioorg Med Chem Lett. 2019 Mar 1;29(5):713-718. doi: 10.1016/j.bmcl.2019.01.012. Epub 2019 Jan 14.

PMID:
30661823
3.

Increased Circulating T Follicular Helper Cells in Iranian Children with Type I Diabetes.

Arab M, Razzaghy-Azar M, Salehi Z, Keshavarz M, Nasli-Esfahani E, Shekarabi M, Izad M.

Iran J Allergy Asthma Immunol. 2018 Dec 3;17(6):557-563.

4.

Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.

Saeedi M, Mohammadi-Khanaposhtani M, Pourrabia P, Razzaghi N, Ghadimi R, Imanparast S, Faramarzi MA, Bandarian F, Esfahani EN, Safavi M, Rastegar H, Larijani B, Mahdavi M, Akbarzadeh T.

Bioorg Chem. 2019 Mar;83:161-169. doi: 10.1016/j.bioorg.2018.10.023. Epub 2018 Oct 11.

PMID:
30366316
5.

Association of serum uric acid with nephropathy in Iranian type 2 diabetic patients.

Razi F, Nasli-Esfahani E, Bandarian F.

J Diabetes Metab Disord. 2018 Mar 29;17(1):71-75. doi: 10.1007/s40200-018-0340-z. eCollection 2018 Jun.

6.

Biology-Oriented Drug Synthesis (BIODS) Approach towards Synthesis of Ciprofloxacin-Dithiocarbamate Hybrids and Their Antibacterial Potential both in Vitro and in Silico.

Esfahani EN, Mohammadi-Khanaposhtani M, Rezaei Z, Valizadeh Y, Rajabnia R, Bagheri M, Bandarian F, Faramarzi MA, Samadi N, Amini MR, Mahdavi M, Larijani B.

Chem Biodivers. 2018 Oct;15(10):e1800273. doi: 10.1002/cbdv.201800273. Epub 2018 Sep 24.

PMID:
30019534
7.

Optimal Glycated Hemoglobin Cutoff Point for Diagnosis of Type 2 Diabetes in Iranian Adults.

Razi F, Khashayar P, Ghodssi-Ghassemabadi R, Mehrabzadeh M, Peimani M, Bandarian F, Nasli-Esfahani E.

Can J Diabetes. 2018 Dec;42(6):582-587. doi: 10.1016/j.jcjd.2018.03.005. Epub 2018 Mar 12.

PMID:
30007767
8.

Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.

Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Nasli Esfahani E, Mahdavi M, Larijani B.

Bioorg Chem. 2018 Oct;80:288-295. doi: 10.1016/j.bioorg.2018.06.035. Epub 2018 Jun 30.

PMID:
29980114
9.

Resveratrol supplementation decreases blood glucose without changing the circulating CD14+CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

Khodabandehloo H, Seyyedebrahimi S, Esfahani EN, Razi F, Meshkani R.

Nutr Res. 2018 Jun;54:40-51. doi: 10.1016/j.nutres.2018.03.015. Epub 2018 Apr 6.

PMID:
29914666
10.

Correction to: The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.

Seyyedebrahimi S, Khodabandehloo H, Nasli Esfahani E, Meshkani R.

Acta Diabetol. 2018 Oct;55(10):1087. doi: 10.1007/s00592-018-1160-9.

PMID:
29909463
11.

Patients' perceptions of patient-provider communication and diabetes care: A systematic review of quantitative and qualitative studies.

Peimani M, Nasli-Esfahani E, Sadeghi R.

Chronic Illn. 2018 Jan 1:1742395318782378. doi: 10.1177/1742395318782378. [Epub ahead of print]

PMID:
29895167
12.

Reply to Letter to the Editor "The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial".

Seyyedebrahimi S, Khodabandehloo H, Esfahani EN, Meshkani R.

Acta Diabetol. 2018 Jul;55(7):755-756. doi: 10.1007/s00592-018-1154-7. Epub 2018 May 23. No abstract available.

PMID:
29796859
13.

Inhibition of Insulin Degrading Enzyme and Insulin Degradation by UV-Killed Lactobacillus acidophilus.

Neyazi N, Motevaseli E, Khorramizadeh MR, Mohammadi Farsani T, Nouri Z, Nasli Esfahani E, Ghahremani MH.

Med Sci (Basel). 2018 May 11;6(2). pii: E36. doi: 10.3390/medsci6020036.

14.

Decreased Serum Level of miR-155 is Associated with Obesity and its Related Metabolic Traits.

Mahdavi R, Ghorbani S, Alipoor B, Panahi G, Khodabandehloo H, Esfahani EN, Razi F, Meshkani R.

Clin Lab. 2018 Jan 1;64(1):77-84. doi: 10.7754/Clin.Lab.2017.170618.

PMID:
29479888
15.

The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.

Seyyedebrahimi S, Khodabandehloo H, Nasli Esfahani E, Meshkani R.

Acta Diabetol. 2018 Apr;55(4):341-353. doi: 10.1007/s00592-017-1098-3. Epub 2018 Jan 22. Erratum in: Acta Diabetol. 2018 Oct;55(10):1087.

PMID:
29357033
16.

The effects of green cardamom supplementation on blood glucose, lipids profile, oxidative stress, sirtuin-1 and irisin in type 2 diabetic patients: a study protocol for a randomized placebo-controlled clinical trial.

Aghasi M, Ghazi-Zahedi S, Koohdani F, Siassi F, Nasli-Esfahani E, Keshavarz A, Qorbani M, Khoshamal H, Salari-Moghaddam A, Sotoudeh G.

BMC Complement Altern Med. 2018 Jan 17;18(1):18. doi: 10.1186/s12906-017-2068-6.

17.

sICAM-1, sVCAM-1 and sE-Selectin Levels in Type 1 Diabetes.

Fathollahi A, Massoud A, Amirzargar AA, Aghili B, Nasli Esfahani E, Rezaei N.

Fetal Pediatr Pathol. 2018 Feb;37(1):69-73. doi: 10.1080/15513815.2017.1405467. Epub 2018 Jan 16.

PMID:
29336634
18.

Effect of treatment of iron deficiency anemia onhemoglobin A1c in type 2 diabetic patients

Naslı-Esfahani E, Larijani B, Amini P, Ghodssi-Ghassemabadi R, Razmandeh R.

Turk J Med Sci. 2017 Nov 13;47(5):1441-1446. doi: 10.3906/sag-1601-27.

PMID:
29151315
19.

LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations.

Razi F, Forouzanfar K, Bandarian F, Nasli-Esfahani E.

J Diabetes Metab Disord. 2017 Nov 3;16:43. doi: 10.1186/s40200-017-0326-2. eCollection 2017.

20.

Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects.

Ghorbani S, Mahdavi R, Alipoor B, Panahi G, Nasli Esfahani E, Razi F, Taghikhani M, Meshkani R.

Arch Physiol Biochem. 2018 Oct;124(4):300-305. doi: 10.1080/13813455.2017.1396349. Epub 2017 Nov 7.

PMID:
29113498
21.

A peer support intervention in improving glycemic control in patients with type 2 diabetes.

Peimani M, Monjazebi F, Ghodssi-Ghassemabadi R, Nasli-Esfahani E.

Patient Educ Couns. 2018 Mar;101(3):460-466. doi: 10.1016/j.pec.2017.10.007. Epub 2017 Oct 12.

PMID:
29055655
22.

Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016).

Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, Saadat M, Esfahani EN, Ganji M, Noshad S, Khajeh E, Ghajar A, Heidari B, Afarideh M, Mechanick JI, Ismail-Beigi F.

Sci Rep. 2017 Oct 18;7(1):13461. doi: 10.1038/s41598-017-13379-z.

23.

Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial.

Ebrahimi ZS, Nasli-Esfahani E, Nadjarzade A, Mozaffari-Khosravi H.

J Diabetes Metab Disord. 2017 Jun 2;16:23. doi: 10.1186/s40200-017-0304-8. eCollection 2017.

24.

Association Between the Polymorphism of Glu298Asp in Exon 7 of the eNOS Gene With Foot Ulcer and Oxidative Stress in Adult Patients With Type 2 Diabetes.

Sadati SM, Radfar M, Hamidi AK, Abdollahi M, Qorbani M, Esfahani EN, Amoli MM.

Can J Diabetes. 2018 Feb;42(1):18-22. doi: 10.1016/j.jcjd.2017.03.001. Epub 2017 May 10.

PMID:
28499789
25.

Amino acid profiling in the gestational diabetes mellitus.

Rahimi N, Razi F, Nasli-Esfahani E, Qorbani M, Shirzad N, Larijani B.

J Diabetes Metab Disord. 2017 Mar 31;16:13. doi: 10.1186/s40200-016-0283-1. eCollection 2017.

26.

Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran.

Nasli-Esfahani E, Farzadfar F, Kouhnavard M, Ghodssi-Ghassemabadi R, Khajavi A, Peimani M, Razmandeh R, Vala M, Shafiee G, Rambod C, Sanjari M, Aalaa M, Ghodsi M, Razi F, Bandarian F, Larijani B.

J Diabetes Metab Disord. 2017 Feb 17;16:9. doi: 10.1186/s40200-017-0291-9. eCollection 2017.

27.

The Circulating Levels of Complement-C1q/TNF-Related Protein 13 (CTRP13) in Patients with Type 2 Diabetes and its Association with Insulin Resistance.

Afrookhteh A, Emamgholipour S, Alipoor B, Moradi N, Meshkani R, Nasli-Esfahani E, Rahimipour A, Shanaki M.

Clin Lab. 2017 Feb 1;63(2):327-333. doi: 10.7754/Clin.Lab.2016.160609.

PMID:
28182339
28.

DHA-enriched fish oil upregulates cyclin-dependent kinase inhibitor 2A (P16INK) expression and downregulates telomerase activity without modulating effects of PPARγ Pro12Ala polymorphism in type 2 diabetic patients: A randomized, double-blind, placebo-controlled clinical trial.

Toupchian O, Sotoudeh G, Mansoori A, Abdollahi S, Ali Keshavarz S, Djalali M, Nasli-Esfahani E, Alvandi E, Chahardoli R, Koohdani F.

Clin Nutr. 2018 Feb;37(1):91-98. doi: 10.1016/j.clnu.2016.12.007. Epub 2016 Dec 19.

PMID:
28024882
29.

Iran Diabetes Research Roadmap (IDRR): the study protocol.

Shafiee G, Nasli-Esfahani E, Bandarian F, Peimani M, Yazdizadeh B, Razi F, Farzadfar F, Larijani B.

J Diabetes Metab Disord. 2016 Dec 15;15:58. doi: 10.1186/s40200-016-0277-z. eCollection 2016.

30.

Mechanisms involved in altered bone metabolism in diabetes: a narrative review.

Ghodsi M, Larijani B, Keshtkar AA, Nasli-Esfahani E, Alatab S, Mohajeri-Tehrani MR.

J Diabetes Metab Disord. 2016 Nov 15;15:52. eCollection 2016. Review.

31.

Vitamin D receptor gene FokI variant in diabetic foot ulcer and its relation with oxidative stress.

Soroush N, Radfar M, Hamidi AK, Abdollahi M, Qorbani M, Razi F, Esfahani EN, Amoli MM.

Gene. 2017 Jan 30;599:87-91. doi: 10.1016/j.gene.2016.11.012. Epub 2016 Nov 9.

PMID:
27836663
32.

Gestational diabetes mellitus its association with obesity: a prospective cohort study.

Pirjani R, Shirzad N, Qorbani M, Phelpheli M, Nasli-Esfahani E, Bandarian F, Hemmatabadi M.

Eat Weight Disord. 2017 Sep;22(3):445-450. doi: 10.1007/s40519-016-0332-2. Epub 2016 Oct 17.

PMID:
27747467
33.

A Systematic Review on the Prevalence of Overweight and Obesity, in Iranian Children and Adolescents.

Djalalinia S, Kelishadi R, Qorbani M, Peykari N, Kasaeian A, Nasli-Esfahani E, Naderimagham S, Larijani B, Farzadfar F.

Iran J Pediatr. 2016 May 10;26(3):e2599. doi: 10.5812/ijp.2599. eCollection 2016 Jun. Review.

34.

Effects of DHA-enriched fish oil on monocyte/macrophage activation marker sCD163, asymmetric dimethyl arginine, and insulin resistance in type 2 diabetic patients.

Toupchian O, Sotoudeh G, Mansoori A, Nasli-Esfahani E, Djalali M, Keshavarz SA, Koohdani F.

J Clin Lipidol. 2016 Jul-Aug;10(4):798-807. doi: 10.1016/j.jacl.2016.02.013. Epub 2016 Mar 8.

PMID:
27578110
36.

Decreased expression of microRNA-21 is associated with increased cytokine production in peripheral blood mononuclear cells (PBMCs) of obese type 2 diabetic and non-diabetic subjects.

Mazloom H, Alizadeh S, Esfahani EN, Razi F, Meshkani R.

Mol Cell Biochem. 2016 Aug;419(1-2):11-7. doi: 10.1007/s11010-016-2743-9. Epub 2016 Jul 2.

PMID:
27370645
37.

Comparative Analytical Performance of Various HbA1c Assays in Iran.

Razi F, Rahnamaye Farzami M, Ebrahimi SA, Nahid M, Bigdeli MG, Sheidaei A, Ghasemian A, Tootee A, Keramati T, Nasli Esfahani E, Larijani B, Pasalar P.

Arch Iran Med. 2016 Jun;19(6):414-9. doi: 0161906/AIM.008.

38.

Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPARγ Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Mansoori A, Sotoudeh G, Djalali M, Eshraghian MR, Keramatipour M, Nasli-Esfahani E, Shidfar F, Alvandi E, Toupchian O, Koohdani F.

J Nutrigenet Nutrigenomics. 2015;8(4-6):195-204. doi: 10.1159/000442792. Epub 2016 Feb 3.

PMID:
26836268
39.

Transitional Meningioma After Fetal Liver-Derived Cell Suspension Allotransplant: A Case Report.

Nasli-Esfahani E, Ghadami M, Amini P, Amiri S, Ghodsi M, Rambod C, Tootee A, Larijani B.

Exp Clin Transplant. 2017 Apr;15(2):231-234. doi: 10.6002/ect.2014.0243. Epub 2016 Jan 20.

40.

Effect of DHA-rich fish oil on PPARγ target genes related to lipid metabolism in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial.

Mansoori A, Sotoudeh G, Djalali M, Eshraghian MR, Keramatipour M, Nasli-Esfahani E, Shidfar F, Alvandi E, Toupchian O, Koohdani F.

J Clin Lipidol. 2015 Nov-Dec;9(6):770-777. doi: 10.1016/j.jacl.2015.08.007. Epub 2015 Aug 29.

PMID:
26687697
41.

Effectiveness of short message service-based intervention (SMS) on self-care in type 2 diabetes: A feasibility study.

Peimani M, Rambod C, Omidvar M, Larijani B, Ghodssi-Ghassemabadi R, Tootee A, Esfahani EN.

Prim Care Diabetes. 2016 Aug;10(4):251-8. doi: 10.1016/j.pcd.2015.11.001. Epub 2015 Dec 2.

PMID:
26653014
42.

Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus.

Hashemian SJ, Kouhnavard M, Nasli-Esfahani E.

J Diabetes Res. 2015;2015:675103. doi: 10.1155/2015/675103. Epub 2015 Oct 20. Review.

43.

Bone structure and turnover in postmenopausal women with type 2 diabetes mellitus.

Razi F, Esmaili M, Esfahani EN, Yaghmaei P, Qorbani M, Mohammadi Z, Keshtkar A, Khashayar P, Larijani B.

Menopause. 2016 Mar;23(3):280-5. doi: 10.1097/GME.0000000000000524.

PMID:
26382315
44.

Association between serum adropin levels and gestational diabetes mellitus; a case-control study.

Beigi A, Shirzad N, Nikpour F, Nasli Esfahani E, Emamgholipour S, Bandarian F.

Gynecol Endocrinol. 2015;31(12):939-41. doi: 10.3109/09513590.2015.1081681. Epub 2015 Sep 17.

PMID:
26376846
45.

Effect of the different assays of HbA1c on diabetic patients monitoring.

Razi F, Nasli Esfahani E, Rahnamaye Farzami M, Tootee A, Qorbani M, Ebrahimi SA, Nahid M, Pasalar P.

J Diabetes Metab Disord. 2015 Aug 4;14:65. doi: 10.1186/s40200-015-0193-7. eCollection 2015.

46.

Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up.

Nasli-Esfahani E, Ghodsi M, Amini P, Keshtkar AA, Amiri S, Mojahed-Yazdi N, Tootee A, Larijani B.

J Diabetes Metab Disord. 2015 Apr 22;14:33. doi: 10.1186/s40200-014-0126-x. eCollection 2015.

47.

Downregulated microRNA-155 expression in peripheral blood mononuclear cells of type 2 diabetic patients is not correlated with increased inflammatory cytokine production.

Mazloom H, Alizadeh S, Pasalar P, Esfahani EN, Meshkani R.

Cytokine. 2015 Dec;76(2):403-408. doi: 10.1016/j.cyto.2015.07.007. Epub 2015 Jul 15.

PMID:
26188366
48.

Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran.

Nasli-Esfahani E, Peimani M, Rambod C, Omidvar M, Larijani B.

Iran J Public Health. 2014 Jun;43(6):713-21.

49.

Effects of Vitamin D and Calcium Supplementation on Micro-architectural and Densitometric Changes of Rat Femur in a Microgravity Simulator Model.

Kouhnavard M, Nasli Esfahani E, Montazeri M, Hashemian SJ, Mehrazma M, Larijani B, Nezami Asl A, Khoshvaghti A, Falsafi A, Lalehfar K, Malekpour K, Vosugh M.

Iran Red Crescent Med J. 2014 Jun;16(6):e18026. doi: 10.5812/ircmj.18026. Epub 2014 Jun 5.

50.

Association of Zinc, Copper and Magnesium with bone mineral density in Iranian postmenopausal women - a case control study.

Razmandeh R, Nasli-Esfahani E, Heydarpour R, Faridbod F, Ganjali MR, Norouzi P, Larijani B, Khoda-Amorzideh D.

J Diabetes Metab Disord. 2014 Mar 6;13(1):43. doi: 10.1186/2251-6581-13-43.

Supplemental Content

Loading ...
Support Center